Results 81 to 90 of about 719 (135)

Guidelines on the Diagnosis and Treatment of Hypertrophic Cardiomyopathy - 2024. [PDF]

Arq Bras Cardiol
Fernandes F, Simões MV, Correia EB, Marcondes-Braga FG, Coelho-Filho OR, Mesquita CT, Mathias Junior W, Antunes MO, Arteaga-Fernández E, Rochitte CE, Ramires FJA, Alves SMM, Montera MW, Lopes RD, Oliveira Junior MT, Scolari FL, Avila WS, Canesin MF, Bocchi EA, Bacal F, Moura LZ, Saad EB, Scanavacca MI, Valdigem BP, Cano MN, Abizaid AAC, Ribeiro HB, Lemos Neto PA, Ribeiro GCA, Jatene FB, Dias RR, Beck-da-Silva L, Rohde LEP, Bittencourt MI, Pereira ADC, Krieger JE, Villacorta Junior H, Martins WA, Figueiredo Neto JA, Cardoso JN, Pastore CA, Jatene IB, Tanaka ACS, Hotta VT, Romano MMD, Albuquerque DC, Mourilhe-Rocha R, Hajjar LA, Brito Junior FS, Caramelli B, Calderaro D, Farsky PS, Colafranceschi AS, Pinto IMF, Vieira MLC, Danzmann LC, Barberato SH, Mady C, Martinelli Filho M, Torbey AFM, Schwartzmann PV, Macedo AVS, Ferreira SMA, Schmidt A, Melo MDT, Lima Filho MO, Sposito AC, Brito FS, Biolo A, Madrini Junior V, Rizk SI, Mesquita ET.   +71 more
europepmc   +1 more source

Clinical and Echocardiographic Particularities of Hypertrophic Cardiomyopathy in a Brazilian Population and its Prognostic Impact. [PDF]

Arq Bras Cardiol
Luzuriaga GDCJ, Arteaga-Fernandez E, Hotta VT, Ianni B, Nastari L, Ramires F, Fonseca GWPD, Mady C, Fernandes F, Cardoso JN.   +9 more
europepmc   +1 more source

Non-sustained Ventricular Tachycardia and Hypertrophic Cardiomyopathy: When to Consider it as a Risk Factor for Sudden Death and Total Mortality? [PDF]

Arq Bras Cardiol
Faganello LS, Pimentel M.
europepmc   +1 more source

PRKAG2 Cardiomyopathy. [PDF]

Arq Bras Cardiol, 2022
Sternick EB.
europepmc   +1 more source

Marcapasso e Cardiomiopatia Hipertrófica Obstrutiva

Journal of Cardiac Arrhythmias, 1996
J. Claude DAUBERT
doaj   +4 more sources

Marfan Syndrome, Hypertrophic Cardiomyopathy And Long QT A Rare Association Causing Sudden Death. [PDF]

Arq Bras Cardiol
Carvalho D, Carvalho S, Pacheco A, Costa C, Carvalho P, Ferreira R, Briosa A.   +6 more
europepmc   +1 more source

Differences Between Two Distinct Hypertrophic Cardiac Conditions: Fabry Disease versus Hypertrophic Cardiomyopathy. [PDF]

Arq Bras Cardiol
Akhan O, Kış M, Güzel T, Zoghi M.
europepmc   +1 more source

[Hypertrophic cardiomyopathy with mid-ventricular phenotype and filamin C mutation, an uncommon case report]. [PDF]

Arch Peru Cardiol Cir Cardiovasc
Orozco Burbano JD, Palacios CH, Saldarriaga Giraldo CI, Durango Gutiérrez LF, Rendón Isaza JC.   +4 more
europepmc   +1 more source

Marked Concentric Myocardial Hypertrophy with Good Postoperative Evolution in a 4 Years Old Child. [PDF]

Arq Bras Cardiol, 2023
Atik E, Leal GN, Jatene MB.
europepmc   +1 more source

Mid-ventricular hypertrophic cardiomyopathy with apical aneurysm: a multimodality imaging case report. [PDF]

Arch Peru Cardiol Cir Cardiovasc
Martinez-Dominguez P, Horna-Noriega M, Santa-Ana-Bayona MJ, Ramírez-Flores S, Horna-Regalado L, Espinola-Zavaleta N.   +5 more
europepmc   +1 more source